Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Gap junction | R-HSA-190861 | map04540 | cefaclor | 6726 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | terconazole | 7251185 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | terconazole | 7251185 | drug-path |
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | tobramycin | 9801 | drug-path |
Axon guidance | R-HSA-422475 | map04360 | tobramycin | 9801 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | tobramycin | 9801 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | tobramycin | 9801 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | tobramycin | 9801 | drug-path |
Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | tobramycin | 9801 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | tobramycin | 9801 | drug-path |
Basal transcription factors | R-HSA-3232118 | map03022 | tobramycin | 9801 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | tobramycin | 9801 | drug-path |
Apoptosis | R-HSA-109581 | map04210 | tolazamide | 5503 | drug-path |
Hedgehog signaling pathway | R-HSA-5358351 | map04340 | tolazamide | 5503 | drug-path |
TGF-beta signaling pathway | R-HSA-168638 | map04350 | tolazamide | 5503 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | tolazamide | 5503 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | tolazamide | 5503 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | tolazamide | 5503 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | pyrazinamide | 1046 | drug-path |
Melanoma | Q9UHD0-PRO_0000015379 | map05218 | pyrazinamide | 1046 | drug-path |